Skip to the page

Data / Public companies / SIC 3841: Surgical and medical instruments and apparatus / Osr Holdings, Inc.

Osr Holdings, Inc.: revenue, net income and total assets from its latest annual report

Updated March 31, 2026. Source: SEC Financial Statement Data Sets, filing 0001213900-26-037395.

Osr Holdings, Inc. reported revenue of $2.9 million, a net loss of $27.1 million and total assets of $171.2 million for the fiscal year ended December 31, 2025, in its annual report (10-K) filed with the SEC on March 31, 2026. It ranks 102nd by revenue of 119 companies in SIC 3841, surgical and medical instruments and apparatus.

The request: Watch Osr Holdings, Inc. (CIK 1840425): each new SEC filing, with revenue and net income. $10 of work on sign-up, no card.

SpecStream is the live web data engine for teams and agents. It reads the annual reports that companies file with the SEC, and this page is that reading. Ask for the companies of an industry, state or city with their website, number of employees and funding added from the web, and each new annual report arrives in your sheet, CRM, Slack or agent as the SEC posts it.

SEC central index key (CIK)
1840425
Industry
SIC 3841, Surgical and medical instruments and apparatus
Business address (city and state)
Bellevue, Washington
Incorporated in
Delaware
Filer category
Non-accelerated filer
Fiscal year ends
December 31
Latest annual report
10-K filed March 31, 2026
Annual and quarterly reports in the data
1 annual, 4 quarterly

Financials for the fiscal year ended December 31, 2025

As filed, in US dollars. The prior year value is the comparison column in the same report.

ItemThis yearPrior yearChangeSource
Revenue$2,905,805$3,530,303-17.7%sec.gov
Operating income$-18,336,003Not listedNot listedsec.gov
Net income$-27,058,541$-10,328,910-162%sec.gov
Total assets$171,238,248$175,239,579-2.3%sec.gov
Total liabilities$44,200,845Not listedNot listedsec.gov
Stockholders' equity$127,037,403Not listedNot listedsec.gov
Cash and cash equivalents$1,700,273Not listedNot listedsec.gov

How it compares

Net margin (net income over revenue)
-931.2%
Revenue change on the prior year
-17.7%
Revenue rank in SIC 3841
102nd of 119
Revenue rank in Washington
49th of 53
Revenue rank among all companies in the data
3,958th of 4,486

Companies next to it by revenue in SIC 3841

Surgical and medical instruments and apparatus, from the same data.

CompanyBusiness addressRevenueNet incomeTotal assetsRevenue change
Intelligent Bio Solutions Inc.New York, NY$4.2 million$-12,430,975$11.9 million38.1%
Tenon Medical, Inc.Los Gatos, CA$3.9 million$-12,556,000$10.8 million20.4%
Icecure Medical LTD.Caesarea$3.4 million$-15,057,000$13.9 million2.7%
Nuo Therapeutics, Inc.Houston, TX$3.3 million$-2,512,216$1.8 million142.7%
Qhslab, Inc.West Palm Beach, FL$2.7 million$457,417$2.2 million26.3%
Femasys IncSuwanee, GA$2.3 million$-18,627,887$20.7 million40.8%
Vycor Medical IncBoca Raton,, FL$1.9 million$-72,426$830,42017.2%
Ebr Systems, Inc.Sunnyvale, CA$1.6 million$-48,758,000$97.2 millionNot listed

Public data from the US Securities and Exchange Commission. Companies are the registrants whose latest annual report (form 10-K, 20-F or 40-F) is in the SEC Financial Statement Data Sets for 2025 Q3 to 2026 Q3, filed through September 30, 2026. Figures are for the whole fiscal year of that report, in US dollars, as the company filed them in XBRL: SpecStream does not adjust them. The SEC does not guarantee the data sets, and they do not replace the filings. Revenue is the revenue tag the company used; banks and funds often use none. Combined totals add each company once and can include a parent and its subsidiary that both file. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.